Purpose

The purpose of this data repository is to provide a secure and centralized storage location and resource for the collection of essential data and medical specimens, across COVID-19 related protocols at Duke.

Condition

Eligibility

Eligible Ages
All ages
Eligible Genders
All
Accepts Healthy Volunteers
No

Criteria


Subjects will be included in this data repository if they meet the enrollment criteria of
any linked/participating IRB-approved protocol, or if they are not enrolled in another
COVID-related study but meet one of the following inclusion criteria:

1. Suspected novel Coronavirus (nCoV) infection (Person Under Investigation) and/or

2. Laboratory proven acute novel Coronavirus (nCoV) infection and/or

3. Primary admitting diagnosis of nCoV infection

Studies will include:

- Any COVID-19 clinical research studies recruiting Duke patients

- Excludes: protocols sharing non-consented EHR data with national/international
repositories and studies that are recruiting community participants

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
COVID-19 Patients Any Duke patient that is being treated for COVID-19.

Recruiting Locations

Duke University Medical Center
Durham, North Carolina 27710
Contact:
Lynn Sutton
919-668-8925
lynn.sutton@duke.edu

More Details

NCT ID
NCT04368234
Status
Recruiting
Sponsor
Duke University

Study Contact

Lynn Sutton
919-668-8925
lynn.sutton@duke.edu

Detailed Description

The aim of this data repository is to provide a secure and centralized storage location and resource for the collection of core variables of interest, as well as the retaining of relevant patient samples, across COVID-19 related protocols at Duke. The core data variables were in-part selected to specifically match those agreed upon by Academic Medical Centers across the U.S., with the intention of aiding the efficiency and effectiveness of de-identified data reuse for population-level research. An additional benefit is that centralized, shared data storage of demographic and longitudinal variables will reduce subject burden, as many questions will now only need to be asked once, rather than each time a given subject joins another COVID-19 related study at Duke. This shared data and bio-repository project will house all the core data for all patients with COVID-19 (or suspected cases), as well as individual participants ICFs for all other participating COVID-19 studies enrolling Duke patients. Each participating study will have its own separate IRB approved protocol. Samples may be either collected specifically by the protocol, or include left-over clinical samples from the testing and treatment of patients with COVID-19 at Duke.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.